Eirik Søfteland
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Eirik Søfteland has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Dag A. Sangnes
Department of Medicine, Haukeland University Hospital, PO Box 1400, N-5021 Bergen, Norway
1 shared publicationGeorg Dimcevski
Department of Medicine, Haukeland University Hospital, PO Box 1400, N-5021 Bergen, Norway
1 shared publication- Iren Drange Hjellestad
Department of Laboratory Medicine and Pathology, Hormone Laboratory, Haukeland University Hospital, Bergen, Norway
1 shared publication - Marianne Catharina Astor
Department of Clinical Medicine and KG Jebsen-Center for Autoimmune Diseases, University of Bergen , 5020 Bergen
1 shared publication - Marjolein Memelink Iversen
Centre on Patient-Reported Outcomes, Department of Research and Development, Haukeland University Hospital, Bergen, Norway
1 shared publication - Roy Miodini Nilsen
Centre for Clinical Research, Haukeland University Hospital, Bergen, Norway
1 shared publication
Latest Publications
- Open Access
- 1 January 2013
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 12 (1) , 1-79
HbA1c versus oral glucose tolerance test as a method to diagnose diabetes mellitus in vascular surgery patients
The diagnosis of diabetes mellitus (DM) is based on either fasting plasma glucose levels or an oral glucose tolerance test (OGTT). Recently, an HbA1c value of ≥ 48 mmol/mol (6.5%) has been included as an additional test to diagnose DM. The purpose of this study was to validate HbA1c versus OGTT as a method to diagnose DM in vascular surgery patients.
- 1 January 2013
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 12 (1) , 1-79
Open AccessHbA1c versus oral glucose tolerance test as a method to diagnose diabetes mellitus in vascular surgery patients
The diagnosis of diabetes mellitus (DM) is based on either fasting plasma glucose levels or an oral glucose tolerance test (OGTT). Recently, an HbA1c value of ≥ 48 mmol/mol (6.5%) has been included as an additional test to diagnose DM. The purpose of this study was to validate HbA1c versus OGTT as a method to diagnose DM in vascular surgery patients.